Pls find enclosed revised Intimation w.r.t Participation in Investor Conference
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma has submitted a revised schedule for two investor conferences due to an error in the previous filing where dates were accidentally swapped. The corrected schedule shows: (1) 360 ONE Capital (B&K) Annual Investor Conference on 29-May-2026 at Grand Hyatt, Santacruz, and (2) ICICI Securities India Investor Conference on 08-Jun-2026. Both meetings will be group or one-on-one format. The company explicitly confirms discussions will be strictly based on already published information, meaning no new material announcements are expected.
This is a routine regulatory compliance filing with no material impact on the stock. It indicates the company is actively engaging with institutional investors but contains no price-sensitive information or new business developments.